PRCT Stock Analysis: Buy, Sell, or Hold?
PRCT - PROCEPT BioRobotics Corporation Common Stock
$26.12
-0.26 (-0.99%)
▼
5d:
+2.83%
30d:
+6.53%
90d:
-6.01%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Smart Money Accumulation
PRCT is down 13.5% this week, but smart money is accumulating calls. Top strike: $32.5 2026-07-17 with 1,285 OI. Call ratio: 88% View Scanner →
Strength: 5.0/10
Get Alerted When PRCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called PRCT this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PRCT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: PRCT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PRCT is currently trading at $26.12, which is considered extended relative to its 30-day fair value range of $23.41 to $26.02.
Technical Outlook: Technically, PRCT is in a strong downtrend. Immediate support is located at $24.25, while resistance sits at $29.10.
Market Sentiment: PRCT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.44 (+16.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PRCT is in a strong downtrend. Immediate support is located at $24.25, while resistance sits at $29.10.
Market Sentiment: PRCT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.44 (+16.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$23.41 -
$26.02
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($30.44)
Trading Range Analysis
30-Day Trading Range
$23.41 -
$26.02
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$24.25
Resistance Level
$29.10
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-29.61
Wall Street Target
$30.44
(+16.6%)
Revenue Growth (YoY)
20.2%
Profit Margin
-31.8%
Share & Embed Analysis
Last updated: May 18, 2026 3:14 AM ET
Data refreshes hourly during market hours. Next update: 4:14 AM
Data refreshes hourly during market hours. Next update: 4:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRCT showing a specific setup today?
Insider Activity (6 Months)
3
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Alaleh Nouri
SELL
5363 shares
2026-03-19
Alaleh Nouri
SELL
304 shares
2026-03-17
Kevin Waters
SELL
706 shares
2026-03-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
